
Posted: January 30, 2020 by quartzdev
Biosimilar Coverage Update
In spring 2019, an article about biosimilars appeared in our provider newsletter. In case you missed it or would like a refresher, download Biosimilars vs. Generics
Note: starting June 1, 2020, Quartz will no longer be covering the brand or innovator product when a biosimilar is available. However, you do not have to wait to order or prescribe a biosimilar — you can start now. Some of the biosimilars will still require prior authorization, similar to the current criteria for the innovator product.